Association between intra-circuit activated clotting time and incidence of bleeding complications during continuous renal replacement therapy using nafamostat mesilate: a retrospective observational study
Not Applicable
- Conditions
- Critically ill patients who required continuous renal replacement therapy
- Registration Number
- JPRN-UMIN000022919
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who required additional extracorporeal intervention including extracorporeal membrane oxygenation or intra-aortic balloon pumping. Patients who were administered other anticoagulants including unfractionated heparin and gabexate mesilate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the incidence of bleeding complications
- Secondary Outcome Measures
Name Time Method